OASMIA PHARMACEUTICAL AB - ADR (OASMY)

CUSIP: 67421W109

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / ADR
Total 13F shares
37,746
Share change
-218,401
Total reported value
$49,000
Price per share
$1.30
Number of holders
3
Value change
-$185,683
Number of buys
2
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 67421W109?
CUSIP 67421W109 identifies OASMY - OASMIA PHARMACEUTICAL AB - ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OASMIA PHARMACEUTICAL AB - ADR (OASMY) as of Q1 2018

As of 31 Mar 2018, OASMIA PHARMACEUTICAL AB - ADR (OASMY) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,746 shares. The largest 3 holders included SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, and UBS Group AG. This page lists 3 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.